Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tap

Showing results (111-120 of 235) with videos related to

Pageof 24
Sort By:
Oncotarget|March 25, 2015
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibitionMarta Kovatcheva, David D Liu, Mark A Dickson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced LeiomyosarcomaLaura M Madanat-Harjuoja, Kelly Klega, Yao Lu, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2022
AI-Radiomics Can Improve Inclusion Criteria and Clinical Trial PerformanceMichal R Tomaszewski, Shuxuan Fan, Alberto Garcia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue SarcomaJoseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
Annals of Surgical Oncology|October 12, 2012
Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumorDaniel R Perez, Raymond E Baser, Michael J Cavnar, et al.
Oncology|June 6, 2015
Outcomes of Systemic Therapy for Patients with Metastatic AngiosarcomaSandra P D'Angelo, Rodrigo R Munhoz, Deborah Kuk, et al.
British Journal of Cancer|October 10, 2013
High-risk features in radiation-associated breast angiosarcomasS P D'Angelo, C R Antonescu, D Kuk, et al.
Head and Neck Pathology|June 17, 2024
DNA Mutational and Copy Number Variation Profiling of Primary Craniofacial Osteosarcomas by Next-Generation SequencingGord Guo Zhu, Chuanyong Lu, Ivana Petrovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomasVladimir Evilevitch, Wolfgang A Weber, William D Tap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomasMatthias R Benz, Johannes Czernin, Martin S Allen-Auerbach, et al.
Pageof 24

Showing results (111-120 of 235) with videos related to

Sort By:
Pageof 24
Oncotarget|March 25, 2015
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibitionMarta Kovatcheva, David D Liu, Mark A Dickson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced LeiomyosarcomaLaura M Madanat-Harjuoja, Kelly Klega, Yao Lu, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2022
AI-Radiomics Can Improve Inclusion Criteria and Clinical Trial PerformanceMichal R Tomaszewski, Shuxuan Fan, Alberto Garcia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue SarcomaJoseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
Annals of Surgical Oncology|October 12, 2012
Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumorDaniel R Perez, Raymond E Baser, Michael J Cavnar, et al.
Oncology|June 6, 2015
Outcomes of Systemic Therapy for Patients with Metastatic AngiosarcomaSandra P D'Angelo, Rodrigo R Munhoz, Deborah Kuk, et al.
British Journal of Cancer|October 10, 2013
High-risk features in radiation-associated breast angiosarcomasS P D'Angelo, C R Antonescu, D Kuk, et al.
Head and Neck Pathology|June 17, 2024
DNA Mutational and Copy Number Variation Profiling of Primary Craniofacial Osteosarcomas by Next-Generation SequencingGord Guo Zhu, Chuanyong Lu, Ivana Petrovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomasVladimir Evilevitch, Wolfgang A Weber, William D Tap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomasMatthias R Benz, Johannes Czernin, Martin S Allen-Auerbach, et al.
Pageof 24